antibiotic rinse with suction
Phase 2Small molecule
antibiotic rinse with suction is one of 33 small molecule programs targeting Appendicitis. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
32
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
64 competitors in Appendicitis
#DrugCompanyPhaseTrials
1Doribax
ShionogiApproved
Flagyl
DDePuy Orthopaedics
Approved
MS Contin
HHikma Pharmaceuticals LLC
Approved
Invanz
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Approved
Naropin
FFresenius Kabi Oncology Ltd.
Approved
Piperacillin/tazobactam
PfizerApproved
Decadron
AAspen Global Incorporated
Approved
Monurol
MMeitheal
Approved
Marcaine
IInnocoll
Approved
Merrem
BB. Braun Medical Inc.
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- PPrisma Health-Upstate